Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation.
Festuccia WT, Laplante M, Brûlé S, Houde VP, Achouba A, Lachance D, Pedrosa ML, Silva ME, Guerra-Sá R, Couet J, Arsenault M, Marette A, Deshaies Y.
Festuccia WT, et al. Among authors: marette a.
J Mol Cell Cardiol. 2009 Jul;47(1):85-95. doi: 10.1016/j.yjmcc.2009.04.011. Epub 2009 May 3.
J Mol Cell Cardiol. 2009.
PMID: 19397913